Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

Trabectedin - CAS# 114899-77-3 Catalog No.:M11024-10 2019 Jan 15

SKU: 66810496620

4.6
USD1880.00 USD1928.00

Pay in 4 interest-free payments of $470.00 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 26 - Aug 31

Live Spec

Trabectedin - CAS# 114899-77-3 Catalog No.:M11024-10 2019 Jan 15Trabectedin (also known as ecteinascidin 743 or ET 743, trade name Yondelis) is an antitumor chemotherapy drug sold by Pharma Mar S. A. and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia, and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U. S. Food and Drug

Store: www.drbramiyohan.com · Domain: www.drbramiyohan.com

Description

2019 Jan 15

3)25-19-17(18(21)22-12-23-19)16(24-25)11-14-9-6-8-13-7-4-5-10-15(13)14/h4-10

CAS Number: 68370-47-8

PubMed Central PMCID: PMC5221699

Trabectedin - CAS# 114899-77-3 Catalog No.:M11024-10 2019 Jan 15Trabectedin (also known as ecteinascidin 743 or ET 743, trade name Yondelis) is an antitumor chemotherapy drug sold by Pharma Mar S. A. and Johnson and Johnson under the brand name Yondelis. It is approved for use in Europe, Russia, and South Korea for the treatment of advanced soft tissue sarcoma. It is also undergoing clinical trials for the treatment of breast, prostate, and paediatric sarcomas. The European Commission and the U. S. Food and Drug

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products